140 related articles for article (PubMed ID: 9428114)
1. Pharmacokinetics of cyclosporine in pediatric long-term liver transplant recipients converted from Sandimmun to Neoral.
Melter M; Rodeck B; Kardorff R; Hoyer PF; Brodehl J
Transpl Int; 1997; 10(6):419-25. PubMed ID: 9428114
[TBL] [Abstract][Full Text] [Related]
2. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
Wahlberg J; Wilczek HE; Fauchald P; Nordal KP; Heaf JG; Olgaard K; Hansen JM; Lokkegaard H; Mueller EA; Kovarik JM
Transplantation; 1995 Oct; 60(7):648-52. PubMed ID: 7570970
[TBL] [Abstract][Full Text] [Related]
3. Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients.
Kelles A; Herman J; Tjandra-Maga TB; Van Damme-Lombaerts R
Pediatr Transplant; 1999 Nov; 3(4):282-7. PubMed ID: 10562972
[TBL] [Abstract][Full Text] [Related]
4. Microemulsion formulation of cyclosporine in pediatric liver transplantation.
Alberti D; Wallemacq P; Falchetti D; de Ville de Goyet J; Rigamonti W; Panzali A; Sokal E; Otte JB; Reding R
Transplantation; 1996 Feb; 61(3):512-4. PubMed ID: 8610371
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
Otto MG; Mayer AD; Clavien PA; Cavallari A; Gunawardena KA; Mueller EA
Transplantation; 1998 Dec; 66(12):1632-40. PubMed ID: 9884251
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.
Taesch S; Niese D
Transpl Int; 1994; 7 Suppl 1():S263-6. PubMed ID: 11271220
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
van Mourik ID; Thomson M; Kelly DA
Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
Keown P; Niese D
Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Neoral and Sandimmun cyclosporin A pharmacokinetic profiles in young renal transplant recipients.
Kabasakul SC; Clarke M; Kane H; Karsten J; Clark G
Pediatr Nephrol; 1997 Jun; 11(3):318-21. PubMed ID: 9203180
[TBL] [Abstract][Full Text] [Related]
10. Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients.
Bistrup C; Nielsen FT; Jeppesen UE; Dieperink H
Nephrol Dial Transplant; 2001 Feb; 16(2):373-7. PubMed ID: 11158415
[TBL] [Abstract][Full Text] [Related]
11. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
12. The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.
Wilczek HE; Berglin E; Blohmé I; Bäckman L; Fehrman I; Källen R; Nyberg G; Säwe J; Wahlberg J
Transplant Proc; 1997; 29(1-2):280-3. PubMed ID: 9122995
[No Abstract] [Full Text] [Related]
13. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a new microemulsion formulation of cyclosporin A (Neoral) in young patients after renal transplantation.
Krmar RT; Wühl E; Ding R; Aulmann M; Schärer K
Transpl Int; 1996; 9(5):476-80. PubMed ID: 8875790
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Neoral in the immediate postoperative period in children post-liver transplantation.
van Mourik ID; Melendez HV; Thomson M; Mieli-Vergani G; Heaton N; Kelly DA
Liver Transpl Surg; 1998 Nov; 4(6):491-8. PubMed ID: 9791160
[TBL] [Abstract][Full Text] [Related]
16. Neoral induction in pediatric renal transplantation.
Bunchman TE; Parekh RS; Flynn JT; Smoyer WE; Kershaw DB; Valentini RP; Pontillo BJ; Sandvordenker J; Brown C; Sedman AB
Pediatr Nephrol; 1998 Jan; 12(1):2-5. PubMed ID: 9502556
[TBL] [Abstract][Full Text] [Related]
17. Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring.
Bökenkamp A; Offner G; Hoyer PF; Vester U; Wonigeit K; Brodehl J
Pediatr Nephrol; 1995 Apr; 9(2):196-8. PubMed ID: 7794718
[TBL] [Abstract][Full Text] [Related]
18. An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoral.
Pasha TM; Wiesner RH; Dahlke LM; Porayko MK; Krom RA
Liver Transpl Surg; 1998 Sep; 4(5):410-5. PubMed ID: 9724479
[TBL] [Abstract][Full Text] [Related]
19. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.
Dunn SP; Cooney GF; Kulinsky A; Falkenstein K; Pierson A; Elder CA; Meligeni J
Transplantation; 1995 Dec; 60(12):1438-42. PubMed ID: 8545871
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin pharmacokinetics in paediatric transplant recipients.
Cooney GF; Habucky K; Hoppu K
Clin Pharmacokinet; 1997 Jun; 32(6):481-95. PubMed ID: 9195117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
